Cite
APA Citation
Anderson, E., Mehta, P., Heywood, J., Rees, B., Bone, H., Robinson, G., Reynolds, D., Salisbury, V., & Mayer, L. (2018). cPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML. Leukemia research, 74, 121–129. http://access.bl.uk/ark:/81055/vdc_100071728820.0x000049